Outcomes registry for better informed treatment of atrial fibrillation II: Rationale and design of the ORBIT-AF II registry

Background Recent clinical trials have demonstrated the safety and efficacy of several non–vitamin K oral anticoagulants (NOACs) for the treatment of atrial fibrillation (AF). However, there are limited data on their use and outcomes in routine clinical practice, particularly among patients newly di...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2014-08, Vol.168 (2), p.160-167
Hauptverfasser:	Steinberg, Benjamin A., MD, MHS, Blanco, Rosalia G., MBA, Ollis, Donna, MS, Kim, Sunghee, PhD, Holmes, DaJuanicia N., MS, Kowey, Peter R., MD, Fonarow, Gregg C., MD, Ansell, Jack, MD, Gersh, Bernard, MB, ChB, DPhil, Go, Alan S., MD, Hylek, Elaine, MD, MPH, Mahaffey, Kenneth W., MD, Thomas, Laine, PhD, Chang, Paul, MD, Peterson, Eric D., MD, MPH, Piccini, Jonathan P., MD, MHS
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticoagulants Anticoagulants - therapeutic use Antithrombins - therapeutic use Atrial Fibrillation - drug therapy Cardiac arrhythmia Cardiovascular Factor Xa Inhibitors Heart attacks Humans Observational Studies as Topic Older people Outcome Assessment (Health Care) Prospective Studies Registries Stroke Ventricular Remodeling
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!